Latest EQL Pharma News & Updates
See the latest news and media coverage for EQL Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish generic pharmaceuticals developer and marketer
eqlpharma.com- Headquarters
- Sweden
- Company type
- Public company
- Number of employees
- 10–60
Latest news about EQL Pharma
Company announcements
-
EQL Pharma's CEO presents Q3 FY 2025/26 results
More information is available via link.
-
EQL Pharma reports record quarter with 29% sales growth
Sales rose to 118.9 MSEK and EBITDA to 24.9 MSEK. A new product was launched and two management members were recruited. Forecast for the full year is 15% growth.
-
EQL Pharma publishes half-year report April–September 2025
Sales increased 1% to 86.4 MSEK in Q2 due to delivery disruptions. EBITDA margin fell to 10%. Forecast for 2025/26: 15% growth and 20% EBITDA.
-
EQL Pharma shares CEO's Q1 FY2025 presentation
The 5.39-minute video offers insights and milestones from the strong quarter.
Media coverage
-
EQL Pharma AB: Mellozzan (melatonin) has been approved in Italy
EQL's key product Mellozzan® has now received Marketing Authorization approval from the health authority in Italy (AIFA), where it will be provided to patients by...
-
EQL Pharma ABSK-FLR Loan 2025(26/28) Bond
The EQL Pharma AB-Bond has a maturity date of 1/24/2028 I18N_bonds#descriptiontext#couponpart#undefinedcoupon The EQL Pharma AB-Bond was issued on the 1/24/2025 with ...
-
EQL Pharma recruits Anne D Jensen as new Chief Sales Officer (CSO) and Carl Lindgren leaves his position as Chief Business Development Officer (CBDO) | MarketScreener
As previously announced, EQL Pharma has decided to strengthen its abilities in international commercial affairs, as a part of its European expansion. The Company has...
-
EQL Pharma Gains Approval for Cystohipp in Germany
EQL Pharma AB ( (SE:EQL)) has provided an update. EQL Pharma AB has received marketing approval in Germany for its key product, methenamine hippurate, branded...
Track EQL Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
EQL Pharma competitors & trending companies
Browse news for competitors to EQL Pharma and other trending companies.
Quagen Pharma
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group